Document is current
Any future updates will be listed below
-
Authors
Knudsen, Hannah K.
Back-Haddix, Sandra
Andrews-Higgins, Shaquita
Goetz, Michael
Davis, Olivia A.
Oyler, Douglas R.
Walsh, Sharon L.
Freeman, Patricia R.
-
Funding
Funding for this research was provided by:
National Institutes of Health and the Substance Abuse and Mental Health Services Administration (UM1DA049406)
National Institutes of Health and the Substance Abuse and Mental Health Services Administration (UM1DA049406)
National Institutes of Health and the Substance Abuse and Mental Health Services Administration (UM1DA049406)
National Institutes of Health and the Substance Abuse and Mental Health Services Administration (UM1DA049406)
National Institutes of Health and the Substance Abuse and Mental Health Services Administration (UM1DA049406)
National Institutes of Health and the Substance Abuse and Mental Health Services Administration (UM1DA049406)
National Institutes of Health and the Substance Abuse and Mental Health Services Administration (UM1DA049406)
- License Information
-
More Information
Article History
Received: 16 September 2024
Accepted: 27 February 2025
First Online: 14 March 2025
Declarations
:
: This study protocol (Pro00038088) was approved by Advarra Inc., the HEALing Communities Study single Institutional Review Board. All participants provided verbal informed consent prior to being interviewed.
: Not applicable.
: HKK, SAH, SBH, MG, OD, PRF, and DRO declare that they have no competing interests. SLW has served as a scientific advisor/consultant for Opiant Pharmaceuticals and Pocket Naloxone.
